Skip to content
Screener

Balchem BCPC Q4 2025 Annual earnings

Reported February 20, 2026 · Before market open

Revenue$263.6MBeat by $4.0M
EPS$1.31Beat by $0.02
Revenue estimate$259.6M
EPS estimate$1.29

Next report

Oct 20, 2026 (in a month)
Revenue estimate$289.2M
EPS estimate$1.54

Financials

Q4 2025

Income statement

See full
Revenue$263.6M+9.8%
Gross profit$93.9M+8.8%
Operating income$52.3M+10.2%
Net income$39.2M+16.8%
EPS (diluted)$1.21+17.5%

Balance sheet

See full
Cash & equivalents$74.6M+50.6%
Total debt$38.1M+2.0%
Total equity$1.3B+9.3%
Total assets$1.7B+7.0%

Cash flow

See full
Operating cash flow$67.3M+28.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$4.97B-6.3%
Enterprise value$4.93B-6.7%
P/E32.1×-9.2×
P/S4.8×-0.8×

Profitability

See full
Gross margin35.7%+0.5pp
Operating margin20.2%+1.0pp
Net margin14.9%+1.5pp

Returns & leverage

See full
Return on equity12.9%+1.2pp
Debt / equity0×0.0×
Current ratio2.1×+0.1×

Segments

By segment

See full
Human Nutrition and Health$166.1M+12.7%
Animal Nutrition and Health$61.2M+4.9%
Specialty Products$34.8M+6.0%

FAQ

When did Balchem report Q4 2025 earnings?
Balchem (BCPC) reported Q4 2025 earnings on February 20, 2026 before market open.
What were Balchem's Q4 2025 revenue and EPS?
Balchem reported revenue of $263.6M and eps of $1.31 for Q4 2025.
Did Balchem beat estimates in Q4 2025?
Revenue beat the consensus estimate of $259.6M by $4.0M. EPS beat the consensus estimate of $1.29 by $0.02.
How did Balchem's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.8% from $240.0M a year earlier and eps grew 27.2% from $1.03.
Where can I find Balchem's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001140361-26-006184) and the 10-K periodic report (0000009326-26-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.